These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 32479813

  • 41. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF.
    Nat Chem Biol; 2009 Jan; 5(1):37-44. PubMed ID: 19029917
    [Abstract] [Full Text] [Related]

  • 42. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.
    Long JZ, Nomura DK, Cravatt BF.
    Chem Biol; 2009 Jul 31; 16(7):744-53. PubMed ID: 19635411
    [Abstract] [Full Text] [Related]

  • 43. Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice.
    Aliczki M, Varga ZK, Balogh Z, Haller J.
    Psychopharmacology (Berl); 2015 Jun 31; 232(12):2157-67. PubMed ID: 25547462
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.
    Terrone G, Pauletti A, Salamone A, Rizzi M, Villa BR, Porcu L, Sheehan MJ, Guilmette E, Butler CR, Piro JR, Samad TA, Vezzani A.
    Epilepsia; 2018 Jan 31; 59(1):79-91. PubMed ID: 29171003
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
    Cao Z, Mulvihill MM, Mukhopadhyay P, Xu H, Erdélyi K, Hao E, Holovac E, Haskó G, Cravatt BF, Nomura DK, Pacher P.
    Gastroenterology; 2013 Apr 31; 144(4):808-817.e15. PubMed ID: 23295443
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
    Alhouayek M, Lambert DM, Delzenne NM, Cani PD, Muccioli GG.
    FASEB J; 2011 Aug 31; 25(8):2711-21. PubMed ID: 21551239
    [Abstract] [Full Text] [Related]

  • 52. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF, Liu QS.
    J Pharmacol Exp Ther; 2009 Nov 31; 331(2):591-7. PubMed ID: 19666749
    [Abstract] [Full Text] [Related]

  • 53. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.
    Bernal-Chico A, Canedo M, Manterola A, Victoria Sánchez-Gómez M, Pérez-Samartín A, Rodríguez-Puertas R, Matute C, Mato S.
    Glia; 2015 Jan 31; 63(1):163-76. PubMed ID: 25130621
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
    Ignatowska-Jankowska B, Wilkerson JL, Mustafa M, Abdullah R, Niphakis M, Wiley JL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2015 May 31; 353(2):424-32. PubMed ID: 25762694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.